As of 2024-12-11, the EV/EBITDA ratio of Exagen Inc (XGN) is -5.69. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. XGN's latest enterprise value is 73.12 mil USD. XGN's TTM EBITDA according to its financial statements is -12.84 mil USD. Dividing these 2 quantities gives us the above XGN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.6x - 10.7x | 9.5x |
| Forward P/E multiples | 8.5x - 12.6x | 10.8x |
| Fair Price | (6.15) - (7.69) | (7.32) |
| Upside | -245.3% - -281.8% | -273.1% |
| Date | EV/EBITDA |
| 2024-12-09 | -5.96 |
| 2024-12-06 | -6.13 |
| 2024-12-05 | -5.96 |
| 2024-12-04 | -6.05 |
| 2024-12-03 | -6.34 |
| 2024-12-02 | -5.64 |
| 2024-11-29 | -5.34 |
| 2024-11-27 | -5.16 |
| 2024-11-26 | -5.30 |
| 2024-11-25 | -5.45 |
| 2024-11-22 | -5.52 |
| 2024-11-21 | -5.27 |
| 2024-11-20 | -5.65 |
| 2024-11-19 | -4.73 |
| 2024-11-18 | -4.00 |
| 2024-11-15 | -3.98 |
| 2024-11-14 | -3.87 |
| 2024-11-13 | -3.66 |
| 2024-11-12 | -3.72 |
| 2024-11-11 | -3.96 |
| 2024-11-08 | -3.80 |
| 2024-11-07 | -3.45 |
| 2024-11-06 | -3.35 |
| 2024-11-05 | -3.26 |
| 2024-11-04 | -3.28 |
| 2024-11-01 | -3.41 |
| 2024-10-31 | -3.22 |
| 2024-10-30 | -3.33 |
| 2024-10-29 | -3.44 |
| 2024-10-28 | -3.47 |
| 2024-10-25 | -3.58 |
| 2024-10-24 | -3.78 |
| 2024-10-23 | -3.65 |
| 2024-10-22 | -3.77 |
| 2024-10-21 | -3.73 |
| 2024-10-18 | -3.84 |
| 2024-10-17 | -3.62 |
| 2024-10-16 | -3.74 |
| 2024-10-15 | -3.59 |
| 2024-10-14 | -3.59 |
| 2024-10-11 | -3.52 |
| 2024-10-10 | -3.59 |
| 2024-10-09 | -3.62 |
| 2024-10-08 | -3.66 |
| 2024-10-07 | -3.92 |
| 2024-10-04 | -4.00 |
| 2024-10-03 | -3.95 |
| 2024-10-02 | -3.83 |
| 2024-10-01 | -3.80 |
| 2024-09-30 | -4.13 |